09
February
Pharmaceutical – Note – [Non-rated] – OTC is still a fertile channel
The industry posted a VND12,048bn revenue (+7.1% yoy, +5,7% qoq) and a VND842bn NPAT (+6.0% yoy, +13.5% qoq) in 4Q22. The 4Q22 aggregated blended gross margin (GM) was 25% (+2.1%p yoy, +0.1%p qoq), while the net margin (NM) nearly stayed the same as 4Q21 with 7.2% (+0.2%p yoy, -0.2%p qoq).